Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PBH
PBH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PBH News
Doseology Sciences Launches New Energy Product Line
2d ago
PRnewswire
Doseology Sciences Launches New Energy Product Line
2d ago
Newsfilter
Prestige Consumer Healthcare Reports Q3 2026 Earnings with Strategic Insights
Feb 05 2026
seekingalpha
Prestige (PBH) Q3 2026 Earnings Call Transcript
Feb 05 2026
NASDAQ.COM
Prestige Consumer Healthcare Q3 Earnings Miss Expectations
Feb 05 2026
seekingalpha
2026 Stock Market and Economic Forecast from Barron’s Roundtable Experts
Jan 09 2026
Barron's
Prestige Consumer Acquires Pillar5 Pharma to Expand Eye Care Product Line
Jan 02 2026
NASDAQ.COM
Premium Brands Acquires Stampede for $662.5 Million
Dec 10 2025
Globenewswire
Prestige Consumer Healthcare Inc. Reports Decline in Q2 Profit, Surpassing Expectations
Nov 06 2025
NASDAQ.COM
RBC Capital Reaffirms Outperform Rating for Premium Brands Holdings, Increases Price Target to C$118
Nov 04 2025
Benzinga
Ariel Focus Fund acquires AJG, PBH, and FI while divesting from ZIMV, CLB, and BIO.
Oct 24 2025
SeekingAlpha
Analysts Predict FHLC Will Hit $78
Oct 23 2025
NASDAQ.COM
Oppenheimer Keeps Outperform Rating on Prestige Consumer, Adjusts Price Target to $72
Oct 21 2025
Benzinga
Prestige Consumer Healthcare Set to Announce Second Quarter Earnings for Fiscal Year 2026
Oct 06 2025
Newsfilter
Prestige Consumer Healthcare Stock Hits Oversold Levels (PBH)
Sep 15 2025
NASDAQ.COM
Prestige Consumer Healthcare to Speak at Barclays Global Consumer Staples Conference
Sep 04 2025
Newsfilter
Show More News